Shenzhen Kangtai Biological Products Co., Ltd. researches and develops, produces, and sells various types of human vaccines in China. Its marketed vaccines include SARS-COV-2 vaccines, HIB conjugate vaccines, 13-valent pneumococcal conjugate vaccines, recombinant hepatitis B vaccines, 23-valent pneumococcal polysaccharide vaccines, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccines, cell-free whitebait b-type haemophilus influenzae combined vaccines, and measles and rubella combined vaccines. The company’s research and development vaccines comprise rabies vaccine for human use, inactivated poliomyelitis vaccine, and live attenuated varicella vaccine. Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is headquartered in Shenzhen, China.
Metrics to compare | 300601 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300601PeersSector | |
---|---|---|---|---|
P/E Ratio | 91.7x | 45.5x | −0.5x | |
PEG Ratio | −1.20 | −0.94 | 0.00 | |
Price/Book | 1.6x | 1.9x | 2.6x | |
Price / LTM Sales | 5.5x | 5.4x | 2.9x | |
Upside (Analyst Target) | 36.1% | 11.9% | 58.9% | |
Fair Value Upside | Unlock | 13.5% | 8.0% | Unlock |